Virology, Nebraska Center for

 

Document Type

Article

Date of this Version

2012

Citation

THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 2, pp. 1220–1228, January 6, 2012

Comments

© 2012 by The American Society for Biochemistry and Molecular Biology, Inc.

Abstract

Background: MOV10 inhibits HIV-1 replication after being packaged.

Results: A Gag binding plus all but one of seven helicase domains are required for MOV10 packaging. Nearly all residues are required for anti-HIV-1 activity. Conclusion: Gag binding is not sufficient for MOV10 packaging, and multiple discontinuous domains regulate MOV10 activity.

Significance: These findings uncover a new packaging mechanism and provide new insights into MOV10 antiviral activity.

Share

COinS